Edwards Lifesciences Net Cash Flow or Change in Cash and Cash Equivalents Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 137.09  1.47  1.06%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow or Change in Cash and Cash Equivalents of Edwards Lifesciences Corporation with missing and latest data points interpolated. Principal component of the cash flow statement representing the amount of increase (decrease) in cash and cash equivalents. Includes Net Cash Flow from Operations, investing Net Cash Flow from Investing and financing Net Cash Flow from Financing for continuing and discontinued operations, and the effect of exchange rate changes on cash Effect of Exchange Rate Changes on Cash .
Net Cash Flow or Change in Cash and Cash Equivalents  10 Years Trend  
Increasing
Slightly volatile
 Net Cash Flow or Change in Cash and Cash Equivalents 
      Timeline 

Regression Statistics

Arithmetic Mean  86,463,158
Geometric Mean  103,140,246
Coefficient Of Variation  141.44
Mean Deviation  86,396,761
Median  109,500,000
Standard Deviation  122,293,926
Range  458,300,000
R Value  0.54
R Squared  0.29
Significance  0.05715
Slope  16,936,408

Edwards Lifesciences Net Cash Flow or Change in Cash and Cash Equivalents Over Time

2016-12-31  211,700,000 
2017-12-31  211,700,000 
2018-12-31  145,421,053 

Other Fundumenentals

My Equities

My Current Equities and Potential Positions
View AllNext
EW - USA Stock
Edwards Lifesciences Corporation
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
$137.09

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.